✦ LIBER ✦

Intravenous or Oral Vinorelbine Plus Capecitabine As First-Line Treatment in HER2– Metastatic Breast Cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials

✍ Scribed by Maria Rosa Strada; Raffaella Palumbo; Antonio Bernardo; Alberto Riccardi; Cristina Teragni; Guido Poggi; Mara Frascaroli; Alessio Amatu; Benedetta Montagna; Federico Sottotetti; Barbara Tagliaferri; Giovanni Bernardo

Book ID: 113538961
Publisher: CIG Media Group, LP.
Year: 2012
Tongue: English
Weight: 423 KB
Volume: 12
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.11.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

All-oral combination of oral vinorelbine

All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial

✍ Tubiana-Mathieu, N; Bougnoux, P; Becquart, D; Chan, A; Conte, P-F; Majois, F; Es 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 203 KB

All-oral combination of vinorelbine and

All-oral combination of vinorelbine and capecitabine as first-line treatment in HER2/Neu-negative metastatic breast cancer

✍ Hesham Tawfik, Yousri Rostom, Hesham Elghazaly 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 211 KB

Intravenous versus oral vinorelbine plus

Intravenous versus oral vinorelbine plus capecitabine as second-line treatment in advanced breast cancer patients. A retrospective comparison of two consecutive phase II studies

✍ Vito Lorusso; Saverio Cinieri; Marianna Giampaglia; Mariangela Ciccarese; Andrea 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Phase II study of single agent oral vino

Phase II study of single agent oral vinorelbine as first-line treatment in patients with HER-2 negative metastatic breast cancer

✍ Mansour, Maged; Mourad, Cynthia 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 244 KB

Trastuzumab plus intravenous or oral vin

Trastuzumab plus intravenous or oral vinorelbine in chemonaive patients with HER-2 overexpressing metastatic breast cancer – final results of an extended phase II trial

✍ G. Bernardo; R. Palumbo; A. Bernardo; C. Teragni; G. Poggi; A. Delmonte; A. Amat 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 62 KB

2124 POSTER Triple combination of oral v

2124 POSTER Triple combination of oral vinorelbine, capecitabine and trastuzumab as first-line treatment in HER2-positive metastatic breast cancer (MBC): latest results of an international phase II trial

✍ A. Chan; V. Ganju; D. Becquart; P.F. Conte; L. Petruzelka; O. Perrot; G. Villano 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 78 KB